Category: News

Prof. Carrier co-authored an article, “Why Pharmaceutical Patent Thickets Are Unique,” with Sean Tu. The article explains the unique harms presented by patent thickets in the pharmaceutical industry… https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4571486

Prof. Carrier publishes an op ed in The Hill calling for a breakup of Live Nation/Ticketmaster… https://thehill.com/opinion/finance/4449148-dont-let-monopolies-hold-taylor-swifts-next-tour-hostage/

Prof. Carrier has two articles nominated for 2024 antitrust article of the year. The first, “Prior Bad Acts and Merger Review” (with Gwendolyn Lindsay Cooley), is in the merger category…https://awards.concurrences.com/en/awards/2024/academic-articles/prior-bad-acts-and-merger-review-4879 The second, “Why Is FRAND Hard?,” is in the intellectual property category…https://awards.concurrences.com/en/awards/2024/academic-articles/why-is-frand-hard-4878

Prof. Carrier gave a Grand Rounds lecture on high cancer drug prices to the Division of Hematology/Medical Oncology in the Department of Medicine at Weill Cornell Medicine.

Together with Gwendolyn J. Lindsay Cooley, Prof. Michael Carrier published “Prior Bad Acts and Merger Review” in the Georgetown Law Journal Online.” The article introduces a framework for considering the prior bad acts of merging firms. It was cited in two statements of the FTC in September, one on the Amgen/Horizon merger and one on … Continue reading Prof. Michael Carrier co-authors “Prior Bad Acts and Merger Review” in Georgetown Law Journal Online…